Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

How Private Equity Oversees the Ethics of Drug Research

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.

Walt Bogdanich
Author: Walt Bogdanich

Written by

Walt Bogdanich

in

Clinical Trials, Conflicts of Interest, Drugs (Pharmaceuticals), Ethics and Official Misconduct, GLP-1 RAs (Drug), Mergers, Acquisitions and Divestitures, Novo Nordisk A/S, Ozempic (Drug), Private Equity, Regulation and Deregulation of Industry, Research
←An American Way of Dress
More Retirees Are Living on Less, and Losing a Means of Help to Pay for Medicare→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube